Cointime

Uygulamayı indirmek için QR kodu tarayın
iOS & Android

Nereus Pharmaceuticals

company
Exit Type
M&A
Exit Date
Jan 1, 2012

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Sanofi Corporate Round — — Detail
Advent International Private Equity(PE) — — Detail
Lotus BioScience Ventures Series D — — Detail
Eminent Venture Capital Series B — — Detail
BankInvest Biomedical Venture Series C — — Detail
Boston Life Science Venture Series C — — Detail